How to Read a Peptide Certificate of Analysis

Read a peptide certificate of analysis as a report about one sample. First match the file to the lot and sample records. Then check the lab, report number, dates, test name, method, stated limit, unit, result, notes, and approval. A field on the page does not prove that it is true or that it fits the item in hand. A result can support only the test question, sample, and method shown. It does not prove each claim about the item. This guide gives a field by field reading path. It also states what the report cannot show on its own.

Begin with the document, not the largest number

A bold result can draw the eye away from the record around it. Start at the top of the report. Name the lab, site, report number, version, page count, sample code, and lot code. Note who asked for the work and who gave the sample to the lab.

The WHO Model Certificate of Analysis lists the sample, batch, method, limit, result, issuer, and approval in its stated drug quality setting. The model says it is an example, not a fixed form. Use its fields as a reading aid. Do not claim that each report must use that layout.

A clean layout is not proof that the report is real. A report number is not proof that the lab issued it. A lot code is not proof that the tested sample came from the lot. Each link needs its own record.

Field 1: issuer, site, and report record

Write down the legal lab name and the site shown on the file. Keep the report number and version. Note the date of issue and the person or role shown as the approver.

Find a contact path on the lab site or another known record, not only on the certificate. Ask the lab to confirm the report number, version, sample code, dates, and approval. Keep the reply with the file.

A logo, code, or signature image can be present on a real file. Its presence alone does not verify the issuer, the person who signed, or the lab scope for the test. If the issuer does not confirm the file, state that report authentication is not established. Do not call it false without more evidence.

Field 2: material name and form

Copy the full material name as written. Note the form, salt, counterion, end groups, or other change when the report gives them. A short peptide name may not show which form the method or mass value represents.

Compare the report name with the item record. Record a mismatch or missing form. Do not fix it by guess. Ask which material the lab received and which form the stated value uses.

The name field states what the report calls the sample. It does not prove identity on its own. Identity support comes from the test, method, sample map, and result within their scope.

Field 3: sample code and lot link

The lot code on a report should be checked against the item, stock, and sample records. The chain may look like this:

1. the item record names lot A;

2. the sampling record says sample B came from lot A;

3. the lab receipt names sample B;

4. the certificate names sample B and report C; and

5. the lab confirms report C.

If one link is absent, write that attribution to the lot is not established. The gap does not prove that no test took place. It may mean that a map has not been supplied.

A matching code is useful record evidence. It does not prove how the sample was drawn, whether it stood for the full lot, how it was held, or whether the item later shipped came from that lot. Those questions need sampling, custody, stock, and order records.

For a deeper lot map, see Batch Specific COA vs Generic Lot COA.

Field 4: dates and the time line

List each date with its label. A report may show sample receipt, test, review, issue, or approval dates. It may also show a lot date, retest date, or change date.

Do not treat these dates as if they mean the same thing. The issue date is not the sample date. A recent report date does not prove that the item is stable now. A test date does not prove when the lot was made.

Read the dates in order. Ask about a gap, change, or report that was replaced. Keep both versions when a new file corrects an old one. A strange time line is a question to resolve, not proof of motive or fraud.

Field 5: test name and method

The test name tells you the question the lab meant to ask. The method tells you how it sought the answer. A name such as identity, chromatography, water, or content is still too broad when the method, version, and test basis are absent.

The FDA guidance Q2(R2) Validation of Analytical Procedures gives a current frame for method validation in its stated drug setting. It ties method performance to the intended use of the method. It does not set one universal method or limit for all peptide reports.

Ask which method and version were used. Check the sample setup, instrument or test type, reference basis, and key system checks when a skilled review needs them. A method name on a certificate does not prove the method was fit for this sample or claim.

Field 6: specification and acceptance criterion

A specification is the set of stated needs used for the review. An acceptance criterion is the limit, range, or condition set for a given result. Read the criterion beside the method and unit.

Ask who owns the specification and which version applied on the test date. A result marked pass cannot be read well when the limit is absent. A limit copied from another method or item may not fit this test.

Do not invent a limit from a blog, old report, or common number. The source for the criterion should show the item, method, purpose, and version. A criterion can guide a result within that scope. It does not make the item safe, lawful, or fit for a use.

Field 7: units, result, and comments

Read the unit before the number. A percent, mass, ratio, count, or mass to charge value answers a different kind of question. Keep less than signs, ranges, and other marks exactly as shown.

Compare the result with the stated criterion. Then read every note. A comment may say that the sample was tested as received, that a field came from the client, or that another lab made part of the result. Such notes can limit what the result supports.

The result is what the issuer reports under the named method. It is not independent proof that the data are true. It does not answer a test that was not run. A single result also does not prove that all units in a lot have the same trait.

Field 8: conclusion and approval

The conclusion should be read against the listed tests and criteria. A phrase such as meets specification should point to a named specification and the results used. It should not be expanded to traits that were not tested.

Approval shows the report was signed or accepted within the issuer system. It does not prove who made the mark or whether the signer had the stated role. Confirm the report through the lab when the file will carry weight.

The FDA page Is It Really FDA Approved explains the scope of FDA approval. A certificate or lab result is not FDA approval. Do not use a COA, lab logo, or result to imply agency approval.

Read common test fields as separate questions

Do not let one result stand in for another.

1. A chromatography result may show detector response and split peaks under that method. It does not show full mass content, identity, potency, or all impurities.

2. A mass spectrometry result may show ion mass to charge data under that method. It does not show full sequence, purity, content, or all identity traits.

3. A content or assay result may show amount under the stated test and basis. It does not show biological action or a result in people.

4. A water or solvent result may show the named trait under that method. It does not show each other impurity or the full storage path.

5. A microbial result may show the named trait under that test. It does not show all item traits or broad safety.

A reported chromatography area percent is not always peptide mass fraction or amount in a vial. It depends on the method, detector, response, integration, and sample. A mass match is also not a full identity or purity finding. Read each result with its own method and limit.

Mark missing fields without making an accusation

Create a short question for each gap. Ask for the current report, sample map, method, limit, unit, comment, or approval that is missing. State which claim cannot yet be tied to the file.

Use clear phrases such as report not confirmed, lot map not established, method not stated, or criterion not shown. These are record findings. They do not prove that the lab, seller, or report is false.

Keep the first file and any reply. Date the review. Reopen it when the report, lot, item, method, or source changes.

Work one report row from left to right

Suppose a report has a test name, a method code, a limit, a unit, a result, and a note. Read them as one row. First ask what trait the test name points to. Next, find the method version. Then check that the limit and result use the same unit. Read the note before you call the row complete.

Now link the row back to the sample. Check that the sample code sits on the same report. Check that the sample code maps to the lot record. Ask who gave the sample to the lab. A sound row with no lot map is still a result about the named sample, not proof about the lot in hand.

Write a one line scope note. For example: this row reports the named trait for sample B under method M and limit L. Then add the open point. The lot map, sample plan, or method fit may still need proof. This short step keeps the result from growing into a claim the report did not make.

Frequently Asked Questions

Does the presence of a COA prove the lot was tested?

No. The file must map to the sample and lot records. A matching code helps, but the sample source and report link still matter. If the map is missing, attribution to the lot is not established.

Does a high chromatography percentage prove purity?

It supports only the result defined by the stated method, detector, unit, and criterion. It is not always mass fraction, content, or a full impurity finding. Read the method and limit before using the number.

Does a mass match prove identity?

It may support a narrow mass based identity question under the stated method. It does not prove full sequence, purity, content, potency, or every identity trait. Charge, ion form, and method details also matter.

Is a COA proof of FDA approval?

No. A certificate reports lab work within its scope. It is not an agency approval. The cited FDA page explains that approval applies to specific items and settings, not to a lab report as such.

What should I write when a key field is missing?

Name the missing field and the claim it leaves open. Use a phrase such as method not stated or lot map not established. Ask for the record. Do not fill the gap by guess or treat absence as proof of fraud.

Sources

1. World Health Organization, WHO Model Certificate of Analysis.

2. Food and Drug Administration, Q2(R2) Validation of Analytical Procedures.

3. Food and Drug Administration, Is It Really FDA Approved.

Educational and legal disclaimer

This page is for education and document review. It is not legal, medical, or lab advice. It gives no human use or dose guide. It does not prove or guarantee identity, purity, content, potency, safety, approval, legal status, trust, compliance, sales, or any business result. Qualified lab staff should review methods and results. Qualified counsel should review legal questions.